Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
AstraZeneca
Relay Therapeutics, Inc.
AstraZeneca
Aminex Therapeutics, Inc.
West German Study Group
AstraZeneca
AstraZeneca
University of Miami
Stemline Therapeutics, Inc.
M.D. Anderson Cancer Center
Imperial College London
AstraZeneca
AstraZeneca
AstraZeneca
Queen Mary University of London
UNICANCER
National Taiwan University Hospital
Memorial Sloan Kettering Cancer Center
University of Nottingham